Evidence map›Paper›PMID 30921317›Full record

ArticlePLoS neglected tropical diseases2019

Limited differentiation among Plasmodium vivax populations from the northwest and to the south Pacific Coast of Colombia: A malaria corridor?

M Andreína Pacheco, Kristan A Schneider, Nora Céspedes, Sócrates Herrera, Myriam Arévalo-Herrera, Ananias A Escalante

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Exploring the genetic progression of MDR1 inCurrent research in microbial sciences · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

M Andreína PachecoDepartment of Biology/Institute for Genomics and Evolutionary Medicine (iGEM), Temple University, Philadelphia, Pennsylvania, United States of America.
Kristan A SchneiderDepartment CB, University of Applied Sciences Mittweida, Mittweida, Germany.
Nora CéspedesCaucaseco Scientific Research Center and Malaria Vaccine and Drug Development Center, Cali, Colombia.
Sócrates HerreraCaucaseco Scientific Research Center and Malaria Vaccine and Drug Development Center, Cali, Colombia.
Myriam Arévalo-HerreraCaucaseco Scientific Research Center and Malaria Vaccine and Drug Development Center, Cali, Colombia.
Ananias A EscalanteDepartment of Biology/Institute for Genomics and Evolutionary Medicine (iGEM), Temple University, Philadelphia, Pennsylvania, United States of America.ORCID 0000-0002-1532-3430
Caucaseco Scientific Research Center · COTemple University · USHochschule Mittweida · DE

Funding

Vector Biology Research and Integrated Vector Management For Malaria ControlU19AI089702 · NIAID · CAUCASECO SCIENTIFIC RESEARCH CENTER · PI RAMIREZ, OSCAR · 2010 to 2016
$11.5M
Landscape Molecular Epidemiology for Malaria EliminationR56AI109416 · NIAID · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI TAYLOR, JESSE · 2014 to 2014
$276k
NIAID NIH HHS R56 AI109416NIAID NIH HHS U19 AI089702
6 · The paper itself

Abstract

backgroundMalaria remains endemic in several countries of South America with low to moderate transmission intensity. Regional human migration through underserved endemic areas may be responsible for significant parasite dispersion making the disease resilient to interventions. Thus, the genetic characterization of malarial parasites is an important tool to assess how endemic areas may connect via the movement of infected individuals. Here, four sites in geographically separated areas reporting 80% of the malaria morbidity in Colombia were studied. The sites are located on an imaginary transect line of 1,500 km from the northwest to the south Pacific Coast of Colombia with a minimal distance of 500 km between populations that display noticeable ethnic, economic, epidemiological, and ecological differences. METHODOLOGY/PRINCIPAL

findingsA total of 624 Plasmodium vivax samples from the four populations were genotyped by using eight microsatellite loci. Although a strong geographic structure was expected between these populations, only moderate evidence of genetic differentiation was observed using a suite of population genetic analyses. High genetic diversity, shared alleles, and low linkage disequilibrium were also found in these P. vivax populations providing no evidence for a bottleneck or clonal expansions as expected from recent reductions in the transmission that could have been the result of scaling up interventions or environmental changes. These patterns are consistent with a disease that is not only endemic in each site but also imply that there is gene flow among these populations across 1,500 km. CONCLUSION /SIGNIFICANCE: The observed patterns in P. vivax are consistent with a "corridor" where connected endemic areas can sustain a high level of genetic diversity locally and can restore parasite-subdivided populations via migration of infected individuals even after local interventions achieved a substantial reduction of clinical cases. The consequences of these findings in terms of control and elimination are discussed.

Indexed as

Endemic DiseasesGenetics, PopulationGenetic VariationAlgorithmsBayes TheoremCluster AnalysisColombiaEpidemiological MonitoringGene FrequencyGenotypeGeographyHumansLinkage DisequilibriumMalaria, VivaxMicrosatellite RepeatsPlasmodium vivax

Identifiers

PMID30921317
PMCPMC6456216
OpenAlexW2923733843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.